French Body Favors Pharmacy Substitution For Biosimilars
But Move Is Not Supported By Wider European Off-Patent Industry
Executive Summary
French off-patent association Gemme has made a bold show of support for pharmacy-level biosimilar substitution in a position statement published by the industry body. However, the proposals run against the views of broader European industry association Medicines for Europe and come against the backdrop of recently-adopted French legislation that ensures doctors will be involved in biologic substitution.